CAS 151213-40-0

(4aS,7aS)-Octahydro-1H-pyrrolo[3,4-b]pyridine

Description:

(4aS,7aS)-Octahydro-1H-pyrrolo[3,4-b]pyridine is a bicyclic organic compound characterized by its unique fused ring structure, which consists of a pyrrolidine and a piperidine moiety. This compound is typically a colorless to pale yellow liquid or solid, depending on its specific form and purity. It is known for its potential applications in medicinal chemistry, particularly in the development of pharmaceuticals due to its ability to interact with biological targets. The stereochemistry indicated by the (4aS,7aS) designation suggests specific spatial arrangements of its atoms, which can significantly influence its biological activity and reactivity. The compound is soluble in various organic solvents, and its reactivity may involve typical functional groups found in nitrogen-containing heterocycles. Safety data should be consulted for handling, as with any chemical substance, to ensure proper precautions are taken during use. Overall, (4aS,7aS)-Octahydro-1H-pyrrolo[3,4-b]pyridine represents a structurally interesting compound with potential utility in various chemical and pharmaceutical applications.

Formula: C₇H₁₄N₂

InChI: InChI=1S/C7H14N2/c1-2-6-4-8-5-7(6)9-3-1/h6-9H,1-5H2/t6-,7+/m0/s1

InChI key: InChIKey=KSCPLKVBWDOSAI-NKWVEPMBSA-N

SMILES: [C@]12([C@@](CNC1)(NCCC2)[H])[H]

Synonyms:

• (1S,6S)-2,8-Diazabicyclo[4.3.0]nonane
• (1S,6S)-cis-2,8-Diazabicyclo[4.3.0]nonane
• (4AS,7aS)-Octahydro-1H-pyrrole[3,4-b]pyridine
• (4aS,7aS)-2,3,4,4a,5,6,7,7a-octahydro-1H-pyrrolo[3,4-b]pyridine dihydrochloride
• (4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine
• (S,S)-2,8-Diazabicyclo[4,3,0]Nonane
• (S,S)-2,8-Diazabicyclo[4,3,0]Onoane
• (S,S)-2,8-Diazabicylco(4,3,0)Nonane
• 1H-Pyrrolo[3,4-b]pyridine, octahydro-, (4aS,7aS)-
• 1H-Pyrrolo[3,4-b]pyridine, octahydro-, (4aS-cis)-
• Cis-Octahydropyrrolo[3,4-B]Pyridine
• Moxifloxacin side chain

1H-Pyrrolo[3,4-b]pyridine, octahydro-, (4aS,7aS)-

CAS: 151213-40-0

Formula: C₇H₁₄N₂

Purity: 97%

Color and Shape: Liquid

Molecular weight: 126.1995

Ref: IN-DA001N6U

(1S,6S)-2,8-Diazabicyclo[4.3.0]Nonane

CAS: 151213-40-0

(1S,6S)-2,8-Diazabicyclo[4.3.0]Nonane

Purity: 98%

Molecular weight: 126.20g/mol

Ref: 54-OR1007933

(4aS,7aS)-Octahydro-1H-pyrrolo[3,4-b]pyridine

CAS: 151213-40-0

Color and Shape: Neat

Ref: 86-MM0885.15

(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane

CAS: 151213-40-0

Formula: C₇H₁₄N₂

Purity: >98.0%(GC)

Color and Shape: Colorless to Light orange to Yellow clear liquid

Molecular weight: 126.20

Ref: 3B-D4210

(4S,7S)-Moxifloxacin Impurity 83

CAS: 151213-40-0

Formula: C₇H₁₄N₂

Molecular weight: 126.20

Ref: 4Z-M-27103

(S,S)-2,8-Diazabicyclo[4.3.0]nonane

Controlled Product

CAS: 151213-40-0

Applications Moxifloxacin intermediate

Formula: C₇H₁₄N₂

Color and Shape: Neat

Molecular weight: 126.20

Ref: TR-D416871

1H-Pyrrolo[3,4-b]pyridine, octahydro-, (4aS,7aS)-

CAS: 151213-40-0

Purity: 97%

Molecular weight: 126.2

Ref: 10-F861928

(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane

CAS: 151213-40-0

(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane is a chiral compound that can be made from the reaction of an organic acid with an amino alcohol. The enantiomers of this compound have shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis. The synthetic process for this compound was originally developed in the 1980s by researchers at the University of Illinois. They were able to show that it was possible to make a carbonyl reduction product using imidodicarbonic acid and an organic solvent. This led to the synthesis of moxifloxacin hydrochloride, which is used as a treatment for bacterial infections such as tuberculosis or pneumonia.

Formula: C₇H₁₄N₂

Purity: Min. 95%

Color and Shape: Colourless To Brown Liquid

Molecular weight: 126.2 g/mol

Ref: 3D-FD14784